A calcium phosphate cement suitable for use in dental and bone prosthesis is disclosed, which include calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said calcium phosphate particles on their surfaces have whiskers or fine crystals having a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
|
1. An injectable paste comprising:
a calcium phosphate composition, the calcium phosphate composition comprising calcium phosphate cement particles, wherein the diameter of the calcium phosphate cement particles is from 0.05 microns to 100 microns, wherein at least a portion of the calcium phosphate particles have whiskers or fine crystals on the surface, and wherein the whiskers or fine crystals have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm; and
an aqueous solution comprising a hardening-promoter;
wherein the paste is non-dispersive in an aqueous solution, and wherein the working time of the paste is between 1.5 minutes to 31 minutes.
2. The injectable paste of
3. The injectable paste of
4. The injectable paste of
5. The injectable paste of
6. The injectable paste of
9. The injectable paste of
10. The injectable paste of
11. The injectable paste of
12. The injectable paste of
13. The injectable paste of
14. The injectable paste of
15. The injectable paste of
16. The injectable paste of
17. The injectable paste of
18. The injectable paste of
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This is a continuation application and claims the benefit of priority under 35 USC § 120 to U.S. patent application Ser. No. 10/414,582 filed on Apr. 16, 2003, which is a continuation-in-part of U.S. patent application Ser. No. 09/615,384, filed Jul. 13, 2000, now abandoned. The disclosure of the prior application is considered part of and is incorporated by reference in the disclosure of this application.
1. Field of the Invention
The present invention is related to a calcium phosphate cement, and in particular a fast-setting calcium phosphate cement, for use in dental and bone prosthesis.
2. Description of the Related Art
A calcium phosphate cement (abbreviated as CPC) has been widely used as an implant or filling material in dental and bone prosthesis, and its technical details can be found in many patents, for examples U.S. Pat. Nos. 4,959,104; 5,092,888; 5,180,426; 5,262,166; 5,336,264; 5,525,148; 5,053,212; 5,149,368; 5,342,441; 5,503,164; 5,542,973; 5,545,254; 5,695,729 and 5,814,681. In general, the prior art calcium phosphate cements suffer one or more drawbacks as follows: 1) additives having a relatively poor bioactivity being required; 2) a complicated preparation process; 3) an undesired setting time or working time of CPC, which are difficult to be adjusted; 4) not capable of being set to a desired shape in water, blood or body fluid; and 5) poor initial strength after setting of the CPC.
An object of the present invention is to provide a calcium phosphate cement.
Another object of the present invention is to provide a calcium phosphate cement comprising particles having whiskers or fine crystals on surfaces of the particles. Still another object of the present invention is to provide a process for preparing a calcium phosphate cement.
A further object of the present invention is to provide a method of treating a bone or a tooth having a defect in a patient by using a calcium phosphate cement.
In order to accomplish the above objects of the present invention a calcium phosphate cement prepared in accordance with the present invention comprises calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said calcium phosphate particles on their surfaces have whiskers or fine crystals having a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm. By adjusting the diameter of the calcium phosphate particles, the width and/or the length of the whiskers or fine crystals, the inventors of the present invention are able to adjust the working time and/or the setting time of the calcium phosphate cement of the present invention to conform to requirements for various purposes. Moreover, the calcium phosphate cement of the present invention is fast-setting, and is non-dispersive in water or an aqueous solution.
A suitable process for preparing the calcium phosphate cement of the present invention comprises mixing a calcium phosphate powder or small pieces of calcium phosphate with a wetting agent, and controlling growth of whiskers or fine crystals on surfaces of said calcium phosphate powder or small pieces of calcium phosphate by an controlling treatment.
Suitable calcium phosphates for use as the calcium phosphate powder or small pieces of calcium phosphate in the present invention can be any known calcium phosphates such as calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite, hydroxyapatite, a mixture thereof and an adduct thereof. Moreover, the shape of the calcium phosphate powder and the shape of the small pieces of calcium phosphate are not limited, which can be spherical or irregular; and the crystal structure thereof can be single crystal, polycrystal, mixed crystals, semi-crystal, or amorphous.
The process for preparing the calcium phosphate cement preferably further comprises grinding the resulting product from the controlling treatment to form calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said whiskers or fine crystals have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
Said controlling treatment is a vacuuming treatment, an organic solvent treatment, a microwave treatment, a heating treatment, or any other treatments which can control growth of whiskers or fine crystals on surfaces of said calcium phosphate powder or small pieces of calcium phosphate.
Said wetting agent is used to wet the calcium phosphate powder or small pieces of calcium phosphate, and preferably is a diluted aqueous solution containing phosphoric acid or phosphate. The amount of said wetting agent mixed with the calcium phosphate powder or small pieces of calcium phosphate, in general, should be enough to wet substantially all the calcium phosphate powder or small pieces of calcium phosphate. However, it is not necessarily the case when said controlling treatment is the organic solvent treatment, where a water miscible organic solvent is added to the mixture of said wetting agent and said calcium phosphate powder or small pieces of calcium phosphate to form a paste for a subsequent processing step.
Preferably, said wetting agent is a diluted aqueous solution containing more than 20 ppm of phosphoric acid or phosphate, more preferably more than 50 ppm, and most preferably more than 100 ppm of phosphoric acid or phosphate.
Preferably, the process for preparing the calcium phosphate cement of the present invention comprises soaking said calcium phosphate powder or said small pieces of calcium phosphate with said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out (a) said heating treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate at a temperature higher than 45° C.; (b) said vacuuming treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate under vacuum; or (c) said microwave treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate by microwave heating. More preferably, the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate is well mixed to form a uniform mixture prior to being subjected to treatment (a), (b) or (c).
Alternatively, the process for preparing the calcium phosphate cement of the present invention comprises mixing said calcium phosphate powder or said small pieces of calcium phosphate with said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out said organic solvent treatment comprising mixing the mixture of said wetting agent and said calcium phosphate powder or small pieces of calcium phosphate with a water miscible organic solvent, and drying the resulting mixture under vacuum. Preferably, said organic solvent treatment is carried out while stirring, and more preferably, the mixture of said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate and said calcium phosphate powder or small pieces of calcium phosphate is well mixed prior to being subjected to said organic solvent treatment.
Preferably, said calcium phosphate particles of the calcium phosphate cement of the present invention have a diameter of 0.2 to 80 microns, and more preferably 0.5 to 50 microns.
The width of a whisker means an average value of lateral cross-sectional diameters of the whisker, and the width of a fine crystal means an average value of the first 30% of the diameters of the fine crystal, which are shorter than the other 70% thereof. The length of a fine crystal means an average value of the last 30% of the diameters of the fine crystal, which are longer than the other 70% thereof.
Preferably, said whiskers or fine crystals have a width ranging from 2 to 70 nm and a length ranging from 5 to 800 nm, and more preferably a length ranging from 10 to 700 nm.
Preferably, said calcium phosphate particles have a molar ratio of calcium to phosphate ranging from 0.5 to 2.5, more preferably 0.8 to 2.3, and most preferably 1.0 to 2.2.
The calcium phosphate cement of the present invention is biocompatible and a paste made therefrom is non-dispersive in water, which has a working time from several minutes to hours and a setting time from a few minutes to hours. Consequently, the calcium phosphate cement of the present invention is extremely suitable for use as an implant or filling material in dental or bone prosthesis, where the paste must contact water, blood or body fluid. Particularly, the paste made from the calcium phosphate cement of the present invention is able to be directly injected into a bone defect or cavity as an implant or filling material.
The present invention also discloses a method of treating a bone or a tooth having a defect in a patient, comprising mixing the calcium phosphate cement of the present invention and a hardening-promoter-containing aqueous solution to form a paste, and a) injecting said paste into a bone defect or cavity of said patient or b) shaping said paste and implanting the resulting shaped paste into a bone defect or cavity of said patient.
In the method of the present invention, said calcium phosphate cement may further comprise a growth factor, a bone morphology protein or a pharmaceutical carrier, or said hardening-promoter-containing aqueous solution further comprises a growth factor, a bone morphology protein or a pharmaceutical carrier.
Said hardening-promoter-containing aqueous solution can be an aqueous solution comprising any known compounds or compositions which enable the solidification of calcium phosphate, for examples phosphates, calcium salts, and fluorides. That is said hardening-promoter-containing aqueous solution may be an aqueous solution comprising phosphate ions, calcium ions, fluorine ions, or phosphate ions together with fluorine ions as a hardening promoter.
The content of said hardening promoter in said hardening-promoter-containing aqueous solution has no special limitation, but preferably ranges from 1 mM to 3 M, and more preferably from 10 mM to 1 M.
The mixing ratio of the calcium phosphate cement of the present invention and said hardening-promoter-containing aqueous solution is not restricted to any particular ranges; however, the amount of said hardening-promoter-containing aqueous solution mixed should be sufficient to provide substantial wetting of the calcium phosphate cement of the present invention. It should be noted that more water can be supplied in-situ from saliva or body fluid, when the paste is injected or implanted into the bone defect or cavity. Further, the content of said hardening promoter in said hardening-promoter-containing aqueous solution should be adjusted to a higher level corresponding to a less amount of said hardening-promoter-containing aqueous solution being mixed.
Heating Treatment
5 g of Ca(H2PO4)2.H2O powder and 1.6 ml of 25 mM phosphoric acid aqueous solution were mixed, and stirred for one minute. The resulting mixture was placed into an oven at 50° C. for 15 minutes, and the resulting dried mixture was mechanically ground for 20 minutes to fine particles after being removed from the oven. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The setting time is the time required when a 1 mm diameter pin with a load of ¼ pounds can be inserted only 1 mm deep into the surface of the paste. The working time is the time after which the paste is too viscous to be stirred. The working time of the paste of this example is 30 minutes and the setting time thereof is one hour.
The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
Vacuuming Treatment
5 g of CaHPO4 (DCPA) powder and 1.2 ml of 25 mM phosphoric acid aqueous solution were mixed, and stirred for one minute. The resulting mixture was placed in a vacuum environment of −100 Pa for 30 minutes, and the resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 20.5 minutes and the setting time thereof is 24 minutes.
The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
Organic Solvent Treatment
5 g of CaHPO4 (DCPA) powder and 1.6 ml of 25 mM phosphoric acid aqueous solution were mixed, and stirred for one minute. To the resulting mixture 1.6 ml of acetone was added while stirring to form a paste followed by placing in a vacuum environment of −100 Pa for one hour, and the resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 20.0 minutes and the setting time thereof is 22.0 minutes.
The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
Microwave Treatment
3 g of a mixed powder of CaHPO4 (DCPA) and Ca4(PO4)2O (TTCP) in 1:1 molar ratio was mixed with 2.0 ml of 25 mM phosphoric acid aqueous solution, and the mixture was stirred for five minutes. The resulting mixture was placed in a microwave oven where it was heated under low power for five minutes. The resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.42 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 2.0 minutes and the setting time thereof is 4.0 minutes.
The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
Heating Treatment
5 g of a mixed powder of DCPA and TTCP in 1:1 molar ratio was mixed with 1.6 ml of 25 mM phosphoric acid aqueous solution, and the mixture was stirred for one minute. The resulting mixture was placed in a high temperature oven at 500° C. for five minutes. The resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 1.5 minutes and the setting time thereof is 2.5 minutes.
The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
Heating Treatment
5 g of a mixed powder of DCPA and TTCP in 1:1 molar ratio was mixed with 1.6 ml of 25 mM phosphoric acid aqueous solution, and the mixture was stirred for one minute. The resulting mixture was placed in a high temperature oven at 1000° C. for one minute. The resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 31 minutes and the setting time thereof is 35 minutes.
The procedures of Example 1 were repeated except that the Ca(H2PO4)2.H2O powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The heating treatments were carried out with conditions listed in Table 1. The performance is also listed in Table 1.
1 g of a mixed powder of DCPA and TTCP in 1:1 mole and 0.4 ml of a diluted phosphoric acid aqueous solution having a pH of 1.96 were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The paste of this example can not set within hours. The performance is listed in Table 1.
The procedures of Example 2 were repeated except that the DCPA powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The performance is listed in Table 1.
The procedures of Example 3 were repeated except that the DCPA powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The performance is listed in Table 1.
The procedures of Example 4 were repeated except that the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The performance is listed in Table 1.
TABLE 1
Setting/working
Dispersive
Controlling treatment
time(min)
in Water
Control Ex. 1
—
—
Yes
Ex. 7
Heating, 50° C.
11.5/6.5
No
Ex. 8
Heating, 100° C.
13.5/8.0
No
Ex. 9
Heating, 150° C.
8.5/8.0
No
Ex. 10
Heating, 500° C.
2.5/1.5
No
Ex. 11
Heating, 1000° C.
35/31
No
Ex. 12
Vacuuming
14.5/11.5
No
Ex. 13
Organic solvent
17.5/16.5
No
Ex. 14
Microwave
3.5/2.5
No
The pastes prepared in Control Example 1 and Example 7 were injected into water via a syringe at 3, 10 and 30 seconds after the paste being formed. The results are shown in
Two cylinders were prepared by separately molding the pastes prepared in Control Example 1 and Example 7, and were then placed in water.
It can be concluded from the results shown in
Two samples of the calcium phosphate cement prepared in Example 7 were observed by transmission electron microscopy (TEM), and the two TEM pictures shown in
The calcium phosphate cement prepared in Example 6 has a particle diameter distribution shown in
The procedures of Example 7 were repeated by using the calcium phosphate powders and the wetting solutions listed in Table 2. The performance is also listed in Table 2.
TABLE 2
Setting/
Disper-
Calcium
Heating
working
sive
phosphate
Wetting
treat-
time
in
powder*
solution
ment
(min)
water
Ex. 15
TCP
Acetic
Yes
10/6.5
No
acid
Control
TCP
—
No
Yes
Ex. 2
Ex. 16
TCP
Acetic
Yes
12.5/8.5
No
acid
Control
TCP
—
No
—
Yes
Ex. 3
Ex. 17
TTCP + DCPA
Phosphoric
Yes
11/18
No
acid
Control
TTCP + DCPA
—
No
—
Yes
Ex. 4
Ex. 18
TTCP + DCPA +
Phosphoric
Yes
—
No
TCP
acid
Control
TTCP + DCPA +
—
No
—
Yes
Ex. 5
TCP
Ex. 19
DCPA + TCP
Phosphoric
Yes
29/24
No
acid
Control
DCPA + TCP
—
No
—
Yes
Ex. 6
*TCP is anhydrous tricalcium phosphate.
TTCP + DCPA is a mixed powder of TTCP and DCPA in 1:1 molar ratio.
TTCP + DCPA + TCP is a mixed powder of TTCP + DCPA and TCP in 1:1 weight ratio.
DCPA + TCP is a mixed powder of DCPA and TCP in 1:2 molar ratio.
DCPA + TCP is a mixed powder of DCPA and TCP in 1:2 molar ratio.
The procedures of Control Example 1 were repeated by using the calcium phosphate powders and the wetting solutions listed in Table 2. The performance is also listed in Table 2.
The procedures of Example 7 were repeated by using the wetting solutions having different pH values listed in Table 3. The performance is also listed in Table 3.
The procedures of Control Example 1 were repeated by using the wetting solutions having different pH values listed in Table 3. The performance is also listed in Table 3.
TABLE 3
Heating
Dispersive
Wetting solution
pH
treatment
in water
Ex. 20
Phosphoric acid
0.56
Yes
No
Control Ex. 7
—
—
No
Yes
Ex. 21
Phosphoric acid
1.03
Yes
No
Ex. 22
Phosphoric acid
1.17
Yes
No
Ex. 23
Phosphoric acid
1.22
Yes
No
Ex. 24
Phosphoric acid
1.32
Yes
No
Ex. 25
Phosphoric acid
2.0
Yes
No
Control Ex. 8
—
—
No
Yes
Ex. 26
Acetic acid + sodium
7.0
Yes
No
carbonate
Control Ex. 9
—
—
No
Yes
Ex. 27
Sodium hydroxide
9.5
Yes
No
Control Ex. 10
—
—
No
Yes
Ex. 28
Sodium hydroxide
12.55
Yes
No
Control Ex. 11
—
—
No
Yes
Ex. 29
Acetic acid
1.96
Yes
No
Control Ex. 12
—
—
No
Yes
Ex. 30
Ethanol
—
Yes
No
Control Ex. 13
—
—
No
Yes
Ex. 31
Deionized water
7.0
Yes
No
Control Ex. 14
—
—
No
Yes
Lin, Jiin-Huey Chern, Ju, Chien-Ping, Chen, Wen-Cheng
| Patent | Priority | Assignee | Title |
| 7686239, | Dec 21 2001 | Etex Corportation | Synthesis of calcium phosphates by mechano-chemical process |
| 7976874, | Jul 13 2000 | VIVEX BIOLOGICS GROUP, INC | Injectable calcium phosphate cements and the preparation and use thereof |
| Patent | Priority | Assignee | Title |
| 3679360, | |||
| 4371484, | Jun 13 1980 | Mitsubishi Mining & Cement Co., Ltd. | Process for making porous sintered body of calcium phosphate |
| 4481175, | Dec 14 1982 | Mitsui Toatsu Chemicals, Inc. | Process for preparing apatite |
| 4518430, | Apr 29 1982 | American Dental Association Health Foundation; AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION, A CORP ILLINOIS | Dental resptorative cement pastes |
| 4553272, | Feb 26 1981 | UNIVERSITY OF PITTSBURGH, THE, A NON-PROFIT CORP OF PA | Regeneration of living tissues by growth of isolated cells in porous implant and product thereof |
| 4612053, | Apr 29 1982 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
| 4623553, | Jun 12 1984 | Oscobal AG | Method of producing a bone substitute material |
| 4959104, | Oct 11 1985 | Mitsui Chemicals, Inc | Self-hardenable material |
| 5017518, | Sep 14 1987 | Asahi Kogaku Kogyo K.K. | Process for producing calcium phosphate ceramics having porous surface |
| 5053212, | Apr 20 1988 | Norian Corporation | Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite |
| 5092888, | May 19 1989 | Tokuyama Soda Kabushiki Kaisha | Hardening material |
| 5149368, | Jan 10 1991 | CERAMEDICAL, INC | Resorbable bioactive calcium phosphate cement |
| 5152791, | Dec 07 1989 | Olympus Optical Co., Ltd. | Prosthetic artificial bone having ceramic layers of different porosity |
| 5164187, | Apr 05 1990 | Norian Corporation | Hydroxyapatite prosthesis coatings |
| 5180426, | Dec 28 1987 | Asahi Kogaku Kogyo K.K. | Composition for forming calcium phosphate type setting material and process for producing setting material |
| 5218035, | Feb 03 1992 | CERAMEDICAL, INC | Phosphate-containing surgical cements |
| 5262166, | Apr 17 1991 | CERAMEDICAL, INC | Resorbable bioactive phosphate containing cements |
| 5336264, | Apr 28 1988 | Norian Corporation | Situ prepared calcium phosphate composition and method |
| 5338356, | Oct 29 1991 | PENTAX Corporation | Calcium phosphate granular cement and method for producing same |
| 5342441, | Jun 26 1991 | Nitta Gelatin Inc. | Biologically compatible hardening material for dental or medical applications |
| 5409982, | Jul 27 1990 | Osaka Cement Co. Ltd. | Tetracalcium phosphate-based materials and process for their preparation |
| 5476647, | Sep 13 1993 | ADA Foundation | Complex calcium and fluoride containing mouth rinses, dentifrices, and chewable tablets |
| 5492768, | Oct 08 1992 | Kyocera Corporation | Porous living body repairing member, and a method of imparting elasticity to it |
| 5496399, | Aug 23 1994 | Norian Corporation | Storage stable calcium phosphate cements |
| 5503164, | Jan 28 1994 | HOWMEDICA OSTEONICS CORP | Device and method for repair of craniomaxillofacial bone defects including burr holes |
| 5522893, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
| 5525148, | Sep 24 1993 | ADA Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
| 5536575, | Jul 27 1990 | Osaka Cement Co., Ltd. | Tetracalcium phosphate-based materials and processes for their preparation |
| 5542973, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
| 5545254, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
| 5550172, | Feb 07 1995 | Ethicon, Inc | Utilization of biocompatible adhesive/sealant materials for securing surgical devices |
| 5569490, | Jul 27 1990 | Osaka Cement Co., Ltd. | Tetracalcium phosphate-based materials and processes for their preparation |
| 5605713, | Nov 22 1991 | Biomet Deutschland GmbH | Process for the preparation of calcium phosphate cements and its application as bio-materials |
| 5607685, | Feb 09 1994 | Biomet Deutschland GmbH | Protracted-release adminstration forms containing clindamycin palmitate |
| 5652016, | Jul 27 1990 | Osaka Cement Co., Ltd. | Tetracalcium phosphate-based materials and processes for their preparation |
| 5683461, | May 19 1995 | Etex Corporation | Synthesis of reactive amorphous calcium phosphates |
| 5683496, | Jun 06 1995 | Norian Corporation | Storage stable calcium phosphate cements |
| 5695729, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
| 5697981, | Aug 23 1994 | Norian Corporation | Method for repairing bone |
| 5702449, | Jun 07 1995 | SDGI Holdings, Inc | Reinforced porous spinal implants |
| 5766669, | Aug 24 1995 | Warsaw Orthopedic, Inc | Sintering process for producing thin films of calcium phosphate entities |
| 5782971, | Oct 16 1992 | Norian Corporation | Calcium phosphate cements comprising amorophous calcium phosphate |
| 5814681, | Oct 13 1994 | Kuraray Co., Ltd. | Restorative composition for hard tissue and dispensing apparatus therefor |
| 5820632, | Apr 20 1988 | Norian Corporation | Prepared calcium phosphate composition and method |
| 5846312, | Aug 23 1994 | Norian Corporation | Storage stable calcium phosphate cements |
| 5891448, | Jan 06 1995 | ADA Foundation | Control of calcium fluoride formation in mouth rinses, dentifrices and gels |
| 5899939, | Jan 21 1998 | Warsaw Orthopedic, Inc | Bone-derived implant for load-supporting applications |
| 5954867, | Sep 24 1993 | ADA Foundation | Self setting calcium phosphate cements and methods for preparing and using them |
| 5958430, | Feb 20 1998 | Battelle Memorial Institute | Thin film composition with biological substance and method of making |
| 5964932, | Aug 23 1994 | Norian Corporation | Storage stable calcium phosphate cements |
| 5976234, | Sep 24 1993 | ADA Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
| 5993535, | Aug 28 1997 | NGK Spark Plug Co., Ltd. | Calcium phosphate cement and calcium phosphate cement composition |
| 5997624, | Jun 04 1996 | ADA Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
| 6005162, | Apr 20 1988 | Norian Corporation | Methods of repairing bone |
| 6013591, | Jan 16 1997 | Massachusetts Institute of Technology | Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production |
| 6013853, | Feb 14 1992 | Board of Regents, The University of Texas System | Continuous release polymeric implant carrier |
| 6018095, | Jun 14 1996 | Bioland | Method for preparing an implantable composite material, resulting material, implant including said material, and kit therefor |
| 6027742, | May 20 1996 | Etex Corporation | Bioresorbable ceramic composites |
| 6077989, | May 28 1996 | 1208211 ONTARIO LIMITED | Resorbable implant biomaterial made of condensed calcium phosphate particles |
| 6083229, | Dec 12 1997 | Norian Corporation | Methods and devices for the preparation, storage and administration of calcium phosphate cements |
| 6117456, | May 20 1996 | Etex Corporation | Methods and products related to the physical conversion of reactive amorphous calcium phosphate |
| 6118043, | Jun 26 1991 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Bone replacement material with FGF |
| 6123731, | Feb 06 1998 | Warsaw Orthopedic, Inc | Osteoimplant and method for its manufacture |
| 6132463, | May 20 1996 | LIFE SCIENCE ENTERPRISES, INC | Cell seeding of ceramic compositions |
| 6149688, | Jun 07 1995 | HOWMEDICA OSTEONICS CORP | Artificial bone graft implant |
| 6162258, | Aug 25 1999 | Warsaw Orthopedic, Inc | Lyophilized monolithic bone implant and method for treating bone |
| 6277149, | Jun 08 1999 | Warsaw Orthopedic, Inc | Ramp-shaped intervertebral implant |
| 6294041, | Feb 06 1998 | Warsaw Orthopedic, Inc | Method for an osteoimplant manufacture |
| 6294187, | Feb 23 1999 | Warsaw Orthopedic, Inc | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
| 6323146, | Sep 01 1995 | Warsaw Orthopedic, Inc | Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity |
| 6325987, | Jan 16 1997 | ORTHOVITA, INC | Minerals and methods for their production and use |
| 6325992, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
| 6332779, | Jul 03 2000 | Warsaw Orthopedic, Inc | Method of hard tissue repair |
| 6340648, | Apr 13 1999 | Covalent Materials Corporation | Calcium phosphate porous sintered body and production thereof |
| 6379453, | Jul 14 1999 | CALCITEC, INC | Process for producing fast-setting, bioresorbable calcium phosphate cements |
| 6440444, | Feb 23 1999 | Warsaw Orthopedic, Inc | Load bearing osteoimplant and method of repairing bone using the same |
| 6458162, | Aug 13 1999 | ORTHOVITA, INC | Composite shaped bodies and methods for their production and use |
| 6478825, | Nov 28 2001 | Warsaw Orthopedic, Inc | Implant, method of making same and use of the implant for the treatment of bone defects |
| 6495156, | May 11 2001 | Merck Patent Gesellschaft mit Beschraenkter Haftung | Biocements having improved compressive strength |
| 6530955, | Jun 08 1999 | Osteotech, Inc. | Ramp-shaped intervertebral implant |
| 6533821, | Jun 22 2000 | BONE SOLUTIONS, INC | Bio-adhesive composition, method for adhering objects to bone |
| 6547866, | Oct 30 2000 | HOWMEDICA OSTEONICS CORP | Porous calcium phosphate cement |
| 6569489, | Mar 11 1998 | DEPUY PRODUCTS INC ; DEPUY PRODUCTS, INC | Bioactive ceramic coating and method |
| 6585992, | Sep 01 1995 | Warsaw Orthopedic, Inc | Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity |
| 6616742, | Aug 30 2001 | CALCITEC, INC | Process for preparing a paste from calcium phosphate cement |
| 6648960, | Jun 26 2002 | CALCITEC, INC | Method of shortening a working and setting time of a calcium phosphate cement (CPC) paste |
| 6670293, | Oct 30 2000 | Howmedica Osteonics Corp. | Porous calcium phosphate cement |
| 6696073, | Feb 23 1999 | Warsaw Orthopedic, Inc | Shaped load-bearing osteoimplant and methods of making same |
| 6719989, | Sep 08 1999 | Asahi Kogaku Kogyo Kabushiki Kaisha | Sustained release drug carrier, and method of manufacturing sustained release drug carrier |
| 6730129, | May 31 1999 | Nobel Biocare Services AG | Implant for application in bone, method for producing such an implant, and use of such an implant |
| 6752831, | Dec 08 2000 | OSTEOTECH, INC | Biocompatible osteogenic band for repair of spinal disorders |
| 6793725, | Jan 24 2001 | ADA Foundation | Premixed calcium phosphate cement pastes |
| 6808561, | Oct 16 2000 | SOUTH CAROLINA, UNIVERSITY OF | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement |
| 6808585, | Jul 03 2000 | Warsaw Orthopedic, Inc | Osteogenic implants derived from bone |
| 6840995, | Jul 14 1999 | CALCITEC, INC | Process for producing fast-setting, bioresorbable calcium phosphate cements |
| 6929692, | Aug 27 2002 | DR AHMET CUNEYT TAS | Calcium phosphate cement composition and a method for the preparation thereof |
| 6953594, | Oct 10 1996 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
| 6955716, | Mar 01 2002 | American Dental Association Foundation | Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates |
| 6960249, | Jul 14 1999 | VIVEX BIOLOGICS GROUP, INC | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface |
| 6994726, | May 25 2004 | CALCITEC, INC | Dual function prosthetic bone implant and method for preparing the same |
| 20020019635, | |||
| 20020073894, | |||
| 20020137812, | |||
| 20020169066, | |||
| 20030019396, | |||
| 20030031698, | |||
| 20030039676, | |||
| 20030055512, | |||
| 20030074081, | |||
| 20030078317, | |||
| 20030120351, | |||
| 20030121450, | |||
| 20030167093, | |||
| 20030216777, | |||
| 20040003757, | |||
| 20040022825, | |||
| 20040031420, | |||
| 20040076685, | |||
| 20040137032, | |||
| 20040175320, | |||
| 20040180091, | |||
| 20040185181, | |||
| 20040186481, | |||
| 20050008759, | |||
| 20050029701, | |||
| 20050069479, | |||
| 20050076813, | |||
| 20050101964, | |||
| 20050184417, | |||
| 20050184418, | |||
| 20050186353, | |||
| 20050186354, | |||
| 20050186449, | |||
| 20050263919, | |||
| 20050263920, | |||
| 20050263921, | |||
| 20050263922, | |||
| 20050263927, | |||
| 20050263928, | |||
| 20050263929, | |||
| 20050263930, | |||
| 20050263931, | |||
| 20050267587, | |||
| 20050267588, | |||
| 20050267589, | |||
| 20050267593, | |||
| 20050267604, | |||
| 20050268819, | |||
| 20050268820, | |||
| 20050268821, | |||
| 20050271740, | |||
| 20050271742, | |||
| 20050274282, | |||
| 20050274286, | |||
| 20050274287, | |||
| 20050274288, | |||
| 20050274289, | |||
| 20050279252, | |||
| 20050279256, | |||
| 20060011099, | |||
| 20060011100, | |||
| EP267624, | |||
| JP6228011, | |||
| RE33161, | Apr 29 1982 | Stryker Technologies Corporation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
| RE33221, | Apr 29 1982 | Stryker Technologies Corporation | Dental restorative cement pastes |
| WO3055418, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Aug 20 2003 | LIN, JIIN-HUEY CHERN | Cana Lab Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 016899 | /0490 | |
| Aug 20 2003 | JU, CHIEN-PING | Cana Lab Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 016899 | /0490 | |
| Aug 20 2003 | CHEN, WEN-CHENG | Cana Lab Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 016899 | /0490 | |
| Mar 14 2004 | Cana Lab Corporation | CALCITEC, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 016899 | /0502 | |
| May 13 2005 | Calcitec, Inc. | (assignment on the face of the patent) | / |
| Date | Maintenance Fee Events |
| Dec 13 2010 | REM: Maintenance Fee Reminder Mailed. |
| May 08 2011 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
| Date | Maintenance Schedule |
| May 08 2010 | 4 years fee payment window open |
| Nov 08 2010 | 6 months grace period start (w surcharge) |
| May 08 2011 | patent expiry (for year 4) |
| May 08 2013 | 2 years to revive unintentionally abandoned end. (for year 4) |
| May 08 2014 | 8 years fee payment window open |
| Nov 08 2014 | 6 months grace period start (w surcharge) |
| May 08 2015 | patent expiry (for year 8) |
| May 08 2017 | 2 years to revive unintentionally abandoned end. (for year 8) |
| May 08 2018 | 12 years fee payment window open |
| Nov 08 2018 | 6 months grace period start (w surcharge) |
| May 08 2019 | patent expiry (for year 12) |
| May 08 2021 | 2 years to revive unintentionally abandoned end. (for year 12) |